Purchase Order 75D30124P19402
Award Date
8/15/24
Potential Completion Date
8/15/24
Potential Value
$44K
Federal Agency
CDC Pittsburgh
Awardee
Abbott Molecular Inc.
Ultimate Awardee
Abbott Laboratories
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Des Plaines, IL 60018, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for an estimated $100,800.00. The contract does not have a set-aside designation. Abbott Molecular, a manufacturer of molecular diagnostic products and services, will provide unspecified "other functions" to support the CDC's operations in Atlanta, Georgia. The award is not...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for $134,673.00 in laboratory services. The award does not utilize a set-aside and has a completion date of September 27, 2028. Abbott Molecular is a manufacturer of molecular diagnostic products and services that has previously provided equipment, reagents, and testing services to...
This federal contract award is to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide a range of molecular diagnostics equipment, reagents, and testing services to the Department of Health and Human Services Centers for Disease Control and Prevention (CDC). The contract has a potential value of $145,589.00 and is a Delivery Order under the Critical Analyzers, Laboratory GSA Schedule contract. The contract does not have a set-aside designation. Through this award, Abbott...
This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract is for the delivery of reagent kits, with a ceiling value of $87,060.00. It was awarded under the General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Critical Analyzers, Laboratory (FSS-66-III), using a Firm Fixed Price pricing type. The contract has a performance period ending on...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order worth $125,096.60 to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for HIV-1 control kits. The order has an anticipated completion date of August 25, 2022 and did not utilize any set-aside designations. Abbott Molecular is a manufacturer of molecular diagnostic products and services that has previously supported federal customers such as the Department of...
This federal contract award is for the provision of reagents and consumables for use on the Abbott M2000SP and Abbott M2000RT molecular diagnostic platforms. The $121,338.60 contract was awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Department of Health and Human Services Centers for Disease Control and Prevention. The contract is a Blanket Purchase Agreement (BPA) call order under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII). No...
This federal contract award was issued by the Defense Health Agency to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide a range of molecular diagnostics equipment, reagents, and testing services. The award, valued at $142,373.50, is a Blanket Purchase Agreement (BPA) call under contract number W91YTZ-12-A-0103, with a period of performance through September 30, 2016. The contract does not have a set-aside designation. Abbott Molecular has a history of providing medical...
The Centers for Disease Control and Prevention, within the Department of Health and Human Services, awarded Abbott Molecular Inc. a $143,595.78 firm fixed price call against the Abbott Laboratories GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. Under this short-term agreement lasting from August 1-15, 2023, Abbott Molecular will provide reagent kits to CDC for use in its disease prevention and health promotion efforts. As the prime contractor, Abbott Molecular will...
This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Centers for Disease Control and Prevention (CDC). The contract is for reagents and consumables under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule contract. The contract has a ceiling value of $79,916.40 and a period of performance through June 30, 2016. This award is not designated as a set-aside contract. Abbott Molecular has previously provided a range of...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price delivery order to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide reagents and consumables for the Abbott M2000SP and M2000RT diagnostic platforms. The $148,793.75 award falls under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits. This award does not utilize a set-aside designation. As a major manufacturer of medical devices and...